PIK3CA kinase and PTEN phosphatase are potent regulators in the PI3K-AKT-mTOR pathway, and mutations in these genes have long been implicated in various tumor types, including breast, colorectal, endometrial, ovary, liver, and gastric malignancies, despite low incidences [29]. The gene discussed is MTOR; the disease is neoplasm.